Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jan 31;9:20. doi: 10.1186/s13287-017-0745-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 5 — Histopathological examination and follicle counts in ovaries. a Control group. b POF group. c hPMSC treatment group. d Summary of follicle count from the ovaries of each group. The following different types of ovarian follicles were observed: primordial follicle (▲), primary follicle (▼), secondary follicle (■), atretic follicle (●). Magnification × 100. Scale bar: 200 μm. Data presented as mean ± SD. *P < 0.05, ***P < 0.001 indicates the statistically significant difference between the groups with and without pZP3 treatment. hPMSC human placenta mesenchymal stem cell, POF premature ovarian failure